Teladoc Health Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Teladoc Health, Inc. income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue2.572.602.412.031.090.550.42
Cost of Revenue0.750.760.740.650.390.180.13
Gross Profit1.821.841.661.380.700.370.29
Operating Expenses
Research & Development0.310.350.330.310.160.060.05
Selling, General & Administrative1.351.371.301.110.890.330.27
Operating Expenses2.032.051.911.621.210.440.36
Operating Income-0.21-0.21-13.65-0.24-0.51-0.08-0.07
Other Income/Expense
Interest Income0.060.050.010.000.000.000.00
Interest Expense-0.020.020.020.08-0.060.000.03
Other Income/Expense-0.01-0.03-13.43-0.070.01-0.010.00
Income
Income Before Tax-0.99-0.22-13.66-0.38-0.58-0.11-0.10
Income Tax Expense0.010.000.000.04-0.09-0.010.00
Net Income-1.00-0.22-13.66-0.43-0.49-0.10-0.10
Net Income - Continuous Operations-1.00-0.22-13.66-0.430.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA0.030.15-13.37-0.08-0.44-0.04-0.04
EBIT-0.21-0.20-13.64-0.30-0.52-0.08-0.07
Depreciation & Amortization0.240.340.260.200.070.040.04
Earnings Per Share
Basic EPS-6.00-1.00-85.00-3.00-5.00-1.00-1.00
Diluted EPS-6.00-1.00-85.00-3.00-5.00-1.00-1.00
Basic Shares Outstanding0.170.160.160.160.090.070.07
Diluted Shares Outstanding0.170.160.160.160.090.070.07